Results 221 to 230 of about 30,427 (262)
Some of the next articles are maybe not open access.
Comparison Between Sporadic and Multiple Endocrine Neoplasia Type 1-Associated Insulinoma.
Journal of the American College of Surgeons, 2022BACKGROUND The differences between sporadic and MEN-1 associated insulinoma are not well described. Herein, we compared demographics, neoplasm characteristics, presentation, and survival in patients with sporadic vs MEN-1 insulinomas including benign and
A. Sada +9 more
semanticscholar +1 more source
Exendin‐4‐based imaging in insulinoma localization: Systematic review and meta‐analysis
Clinical Endocrinology, 2021Glucagon‑like peptide‑1 receptor (GLP‐1 R) based imaging has shown higher sensitivity for insulinoma localization as compared to other anatomic/functional imaging.
Ravikumar Shah +9 more
semanticscholar +1 more source
Current Treatment Options in Oncology, 2003
Insulinomas are the most common islet cell tumors and are located almost exclusively in the pancreas. Most of these tumors are sporadic, but they may also be associated with the multiple endocrine neoplasia type I syndrome. More than 90% of insulinomas are benign. Preoperative radiographic localization may prove difficult.
Alan P.B. Dackiw, Andrew R. Burns
openaire +3 more sources
Insulinomas are the most common islet cell tumors and are located almost exclusively in the pancreas. Most of these tumors are sporadic, but they may also be associated with the multiple endocrine neoplasia type I syndrome. More than 90% of insulinomas are benign. Preoperative radiographic localization may prove difficult.
Alan P.B. Dackiw, Andrew R. Burns
openaire +3 more sources
Outcome after surgical management of canine insulinoma in 49 cases.
Veterinary and Comparative Oncology, 2020Canine insulinoma has historically been associated with a poor prognosis, however prolonged survival times have recently been reported. Prognostic indicators that are available preoperatively are of limited predictive accuracy, and consensus on post ...
N. Cleland +5 more
semanticscholar +1 more source
Current Opinion in Endocrinology & Diabetes, 2000
Insulinoma is the most common pancreatic islet cell tumor, usually presenting with symptoms of neuroglycopenia. Diagnosis depends on a high index of suspicion, together with the demonstration of endogenous hyperinsulinemic hypoglycemia. Although the requirement for preoperative localization is controversial, the minimally invasive but highly sensitive ...
Tso, AWK, Lam, KSL
openaire +3 more sources
Insulinoma is the most common pancreatic islet cell tumor, usually presenting with symptoms of neuroglycopenia. Diagnosis depends on a high index of suspicion, together with the demonstration of endogenous hyperinsulinemic hypoglycemia. Although the requirement for preoperative localization is controversial, the minimally invasive but highly sensitive ...
Tso, AWK, Lam, KSL
openaire +3 more sources
Experimental and Clinical Endocrinology & Diabetes, 2009
Insulinomas are rare, mostly benign neuroendocrine tumours with an incidence of approximately four cases per million person per year. Only isolated case reports of insulinomas occurring in pregnancy have been documented. Clinical signs and symptoms of insulinoma appear to be attenuated and, in some cases, even masked by pregnancy.
B Besemer, K Müssig
openaire +3 more sources
Insulinomas are rare, mostly benign neuroendocrine tumours with an incidence of approximately four cases per million person per year. Only isolated case reports of insulinomas occurring in pregnancy have been documented. Clinical signs and symptoms of insulinoma appear to be attenuated and, in some cases, even masked by pregnancy.
B Besemer, K Müssig
openaire +3 more sources
Neuroendocrinology, 2004
More than 90% of insulinomas are benign tumors. Insulinomas cause hypoglycemia and thereby symptoms of neuroglycopenia and catecholamine response. During symptoms, blood glucose levels should be less than 40 mg/dl (less than 2.2 mmol/l), concomitant insulin levels should be ≧6 IU/ml (≧43 pmol/l) and concomitant C-peptide levels ≧0.2 pmol/l.
openaire +4 more sources
More than 90% of insulinomas are benign tumors. Insulinomas cause hypoglycemia and thereby symptoms of neuroglycopenia and catecholamine response. During symptoms, blood glucose levels should be less than 40 mg/dl (less than 2.2 mmol/l), concomitant insulin levels should be ≧6 IU/ml (≧43 pmol/l) and concomitant C-peptide levels ≧0.2 pmol/l.
openaire +4 more sources
Baillière's Clinical Gastroenterology, 1996
Symptoms most characteristically diagnostic of insulinoma are those of neuroglycopenia. The combination of hypoglycemia and endogenous hyperinsulinemia are pathognomonic of insulinoma. Several localization techniques are available, the choice of which best depends on the best expertise at individual institutions.
openaire +5 more sources
Symptoms most characteristically diagnostic of insulinoma are those of neuroglycopenia. The combination of hypoglycemia and endogenous hyperinsulinemia are pathognomonic of insulinoma. Several localization techniques are available, the choice of which best depends on the best expertise at individual institutions.
openaire +5 more sources